Article Versions Notes

Alvisi MF, Ganzinelli M, Linardou H, Caiola E, Lo Russo G, Cecere FL, Bettini AC, Psyrri A, Milella M, Rulli E, et al. Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy. Journal of Clinical Medicine. 2020; 9(8):2438. https://doi.org/10.3390/jcm9082438

Alvisi, Maria Francesca, Monica Ganzinelli, Helena Linardou, Elisa Caiola, Giuseppe Lo Russo, Fabiana Letizia Cecere, Anna Cecilia Bettini, Amanda Psyrri, Michele Milella, Eliana Rulli, and et al. 2020. "Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy" Journal of Clinical Medicine 9, no. 8: 2438. https://doi.org/10.3390/jcm9082438

Alvisi, M. F., Ganzinelli, M., Linardou, H., Caiola, E., Lo Russo, G., Cecere, F. L., Bettini, A. C., Psyrri, A., Milella, M., Rulli, E., Fabbri, A., De Maglie, M., Romanelli, P., Murray, S., Ndembe, G., Broggini, M., Garassino, M. C., & Marabese, M. (2020). Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy. Journal of Clinical Medicine, 9(8), 2438. https://doi.org/10.3390/jcm9082438